Kyprolis 60 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQU9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,525
Award facts
- Contract value 100% obligated
- $17,525.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,525.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Kyprolis 60 mg vials, with an ultimate completion date of February 10, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. Kyprolis (carfilzomib) is a proteasome inhibitor used in oncology treatment, reflecting the contractor's role in delivering specialized pharmaceutical commodities across multiple therapeutic domains to government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FQU9B?
SPE2DR26FQU9B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU9B worth?
The government has obligated $17,525 on SPE2DR26FQU9B.
Is contract SPE2DR26FQU9B an order under another contract?
Yes. SPE2DR26FQU9B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU9B competed?
The extent of competition for SPE2DR26FQU9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award